May 27, 2021
Two first-year graduate students discuss their research into SARS-CoV-2 variants
April 23, 2021
Dr. Peter Santa Maria continues his SPARK journey to understand and treat chronic ear infection
March 24, 2021
SPARK staff lead an effort to characterize cardiovascular biomarkers of COVID-19 to better treat patients
February 10, 2021
Advisor participation is voluntary with no compensation. So what do advisors get out of the program? In their own words.
January 22, 2021
What is passive immunization, and why is the use of IgY antibodies from chickens in a preventative therapy so advantageous?
December 17, 2020
Preparing for a pandemic part 2: How nasal drops are easy and inexpensive to produce worldwide
December 9, 2020
Nasal drops technology could be a blueprint to combat a future outbreak
November 24, 2020
SPARK is developing a unique approach to fight coronavirus, but we need your help
October 14, 2020
Medicinal chemist and blogger Derek Lowe offers questions and suggestions on the state of drug discovery – how can we improve?
August 26, 2020
Stanford researchers review drug repurposing approaches that could be key to combating COVID-19
August 5, 2020
Dr. Russ Altman explores machine learning’s usefulness for predicting a gene’s effect on drug metabolism.
July 15, 2020
Animal models of disease are crucial tools for drug development
June 17, 2020
Our SPARK GLOBAL affiliates in Africa gave us their perspective and response to the COVID-19 pandemic.
April 22, 2020
Why will it take a year or longer for a vaccine to be ready? The answer lies in the development process.
March 11, 2020
A deeper dive into what makes the program successful